Thrombophilias – selected clinical aspects useful in cardiology Review article
Article Sidebar
Main Article Content
Abstract
Thrombophilia is a predisposition to form clots. It can arise from genetic factors, acquired changes in the clotting mechanism, or, more commonly, an interaction between genetic and acquired factors. Venous and arterial thromboembolism seems to be a challenge to clinicians. Nowadays, due to progress in medical science, there are major advances in our understanding of defects that predispose to thrombosis. This knowledge facilitates diagnosis, proper treatment and prophylaxis.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Pasierski T., Undas A., Zawilska K., Sosnowski C.: Leczenie przeciwzakrzepowe. Medycyna Praktyczna, Kraków 2007.
3. Choroby wewnętrzne tom II. Wyd. I. Szczeklik A. (red.). Medycyna Praktyczna, Kraków 2006: 1579-1582.
4. Kardiologia z elementami angiologii. Część II. Pruszczyk P., Hryniewiecki T., Drożdż J. (red.). Medical Tribune Polska, Warszawa 2009: 428-439.
5. Shen I., Dahlback B.: Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIII. Biol. Chem. 1994; 269(29): 18735-18738.
6. Koster T., Rosendaal F.R., de Ronde H. et al.: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506.
7. Martinelli I., Mannucci P.M., De Stefano V. et al.: Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998 Oct 1; 92(7): 2353-2358.
8. Clinical guidelines for testing for heritable thrombophilia. BJH 2010; 149: 209-220.
9. Morris J.G., Singh S., Fisher M.: Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke 2010 Dec; 41(12): 2985-90.
10. Green D.: Thrombophilia and stroke. Topics on stroke rehabilitation, 2003.
11. Boekholdt S.M., Kramer M.H.: Arterial Thrombosis and the role of thrombophilia. Semin. Thromb. Hemost. 2007 Sep; 33(6): 588-596.
12. Baglin T., Luddington R., Brown K., Baglin C.: Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-526.
13. Christiansen S.C., Cannegieter S.C., Koster T. et al.: Thrombophilia, clinical factors, and recurrent venous thrombotic events. J. Am. Med. Ass. 2005; 293: 2352-61.
14. Langois N.J., Wells P.S.: Risk of venous thromboembolismin relatives of symptomatic probands with thrombofilia: a systematic review. Thromb. Hemost. 2003; 90: 17-26.
15. Jennings I., Kitchen S., Woods T.A., Preston F.E.: Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin. Thromb. Hemost. 2005 Feb; 31(1): 66-72.
16. Kearon C., Julian J.A., Kovacs M.J. et al.: Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood 2008; 112(12): 4432-6.
17. Martinelli I., Franchini M., Mannucci P.M.: How I treat rare venous thromboses. Blood 2008; 112(13): 4818-4823.